SCHEMBL24730299

SCHEMBL24730299

CC1(C)c2ccccc2C2(c3ccccc3-c3c2cc(Cl)c2c3[nH]c3ccccc32)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.41
CDK4 P11802 8/20 0.40
CCND1 P24385 8/20 0.40
CAMK2B Q13554 6/20 0.40
CAMK2G Q13555 6/20 0.40
CAMK2D Q13557 6/20 0.40
CAMK2A Q9UQM7 6/20 0.40
CCNE2 O96020 6/20 0.40
CCNE1 P24864 6/20 0.40
CDK2 P24941 6/20 0.40
PARP1 P09874 2/20 0.39
CDK5 Q00535 3/20 0.38
CDK5R1 Q15078 3/20 0.38
CCNB2 O95067 3/20 0.38
CDK1 P06493 3/20 0.38
CCNB1 P14635 3/20 0.38
CCNB3 Q8WWL7 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24730495 0.91 CHEK1 (0.44) CHEK1CDK4CCND1CAMK2BCAMK2G
SCHEMBL24730287 0.78 CDK4 (0.41) CHEK1CDK4CCND1CAMK2BCAMK2G
SCHEMBL24730298 0.76 CDK4 (0.43) CHEK1CDK4CCND1CAMK2BCAMK2G
SCHEMBL15126976 0.72 CHEK1 (0.46) CHEK1CDK4CCND1CAMK2BCAMK2G
SCHEMBL22920764 0.72 PARP1 (0.40) CHEK1CDK4CCND1CAMK2BCAMK2G
SCHEMBL24730498 0.72 PGR (0.40) CHEK1CDK4CCND1CAMK2BCAMK2G
SCHEMBL15840151 0.72 PGR (0.48) CHEK1CDK4CCND1CDK5CDK5R1
SCHEMBL20199544 0.72 KIF11 (0.44) CDK4CCND1CAMK2BCAMK2GCAMK2D
SCHEMBL15840146 0.71 KIF11 (0.46) CDK4CCND1CAMK2BCAMK2GCAMK2D
SCHEMBL24730496 0.71 DYRK1A (0.42) CHEK1CDK4CCND1CAMK2BCAMK2G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-17 US disclosed
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-17 US disclosed
WO-2022213794-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2022-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF OCIAD1, OCIAD2, EPCAM CHEK1 2691/4885CDK4 1919/4885CCND1 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.